Skip to main content
XOMA Royalty Corp logo

XOMA Royalty Corp — Investor Relations & Filings

Ticker · XOMA ISIN · US98419J3059 US Financial and insurance activities
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2025-08-14 Director's Dealing
Country US United States of America
Listing US XOMA

About XOMA Royalty Corp

https://xoma.com/

XOMA Royalty Corp. is a biotech royalty aggregator that acquires economic rights to potential future milestone and royalty payments. The company's portfolio consists of assets associated with pre-commercial clinical candidates being developed by various pharmaceutical and biotech partners. In exchange for these economic rights, XOMA provides its partners with non-dilutive, non-recourse capital to fund their internal drug development programs. This portfolio-based strategy, encompassing over 120 assets, is designed to diversify risk away from single-asset clinical outcomes. XOMA focuses on managing these royalty assets rather than direct drug development.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2025-08-14 English
PRIMARY DOCUMENT
Director's Dealing
2025-08-14 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 13, 2025, reporting the issuance of a press release announcing financial results for the fiscal quarter ended June 30, 2025. The text states that the full press release is attached as an exhibit and incorporated by reference, but the 8-K itself does not contain detailed financial statements or substantive financial data. The document is short (3891 characters) and primarily serves as an announcement of the earnings release rather than the earnings release itself. According to the rules, such a document should be classified as an Earnings Release (ER) if it contains key highlights only, but since this is a Form 8-K announcing the press release and attaching it as an exhibit, it is best classified as Regulatory Filings (RNS) because it is a general regulatory announcement and does not contain the full earnings release text or detailed financial data itself.
2025-08-13 English
10-Q
Interim / Quarterly Report Q2 2025
2025-08-13 English
SC TO-T/A Filing
Merger & Acquisition Classification · 100% confidence The document is a Schedule TO filing, which is a Tender Offer Statement under the Securities Exchange Act of 1934. It includes detailed information about a tender offer, the completion of a merger, and the delisting of the company's shares from Nasdaq. The document is an official regulatory filing related to a merger and tender offer, including amendments and supplements to the original Schedule TO. It is not a full annual or quarterly report, nor is it a simple announcement or certification. The presence of the tender offer details, merger completion, and delisting notice indicates this is related to merger and acquisition activity filings. Therefore, the appropriate classification is Merger & Acquisition (MA).
2025-08-11 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.